BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24610925)

  • 21. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease.
    Bae E; Cha RH; Kim YC; An JN; Kim DK; Yoo KD; Lee SM; Kim MH; Park JT; Kang SW; Park JY; Lim CS; Kim YS; Yang SH; Lee JP
    Medicine (Baltimore); 2017 May; 96(19):e6666. PubMed ID: 28489742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
    Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
    Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of estimated glomerular filtration rate on the 15-year outcome after coronary artery bypass surgery.
    Kangasniemi OP; Mahar MA; Rasinaho E; Satomaa A; Tiozzo V; Lepojärvi M; Biancari F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):198-202. PubMed ID: 18068374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
    Kon S; Konta T; Ichikawa K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
    Clin Exp Nephrol; 2018 Apr; 22(2):346-352. PubMed ID: 28744566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Predictive Role of Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio According to Renal Function in Patients with Acute Myocardial Infarction.
    Kim JS; Kim W; Woo JS; Lee TW; Ihm CG; Kim YG; Moon JY; Lee SH; Jeong MH; Jeong KH;
    PLoS One; 2016; 11(10):e0165484. PubMed ID: 27788233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
    Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.
    Chen HY; Tsai WC; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Medicine (Baltimore); 2015 Mar; 94(10):e619. PubMed ID: 25761189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.
    Drechsler C; Delgado G; Wanner C; Blouin K; Pilz S; Tomaschitz A; Kleber ME; Dressel A; Willmes C; Krane V; Krämer BK; März W; Ritz E; van Gilst WH; van der Harst P; de Boer RA
    J Am Soc Nephrol; 2015 Sep; 26(9):2213-21. PubMed ID: 25568176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictive value of s-cystatin C for mortality after coronary artery bypass surgery.
    Dardashti A; Nozohoor S; Algotsson L; Ederoth P; Bjursten H
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):139-46. PubMed ID: 27056756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation.
    Lai CF; Lin YH; Huang KH; Chueh JS; Wu VC;
    Hypertens Res; 2024 Jan; 47(1):233-244. PubMed ID: 37714953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
    Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
    Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
    Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
    Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.
    Bowe B; Xie Y; Xian H; Balasubramanian S; Zayed MA; Al-Aly Z
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1784-1793. PubMed ID: 27515591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.
    Silbernagel G; Schöttker B; Appelbaum S; Scharnagl H; Kleber ME; Grammer TB; Ritsch A; Mons U; Holleczek B; Goliasch G; Niessner A; Boehm BO; Schnabel RB; Brenner H; Blankenberg S; Landmesser U; März W
    Eur Heart J; 2013 Dec; 34(46):3563-71. PubMed ID: 24014391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.